Hypothalamic obesity

Last updated

Hypothalamic obesity (abbreviated HO or HyOb) is a rare condition that can be congenital or acquired. Congenital causes include Prader-Willi syndrome and mutations of LEP (leptin gene), LEPR, POMC, MC4R, and CART. It can also result from injuries to the hypothalamus either from trauma, therapeutic radiation, brain surgery, and especially craniopharyngioma and its treatments. Possible treatments include bariatric surgery and melanocortin 4 receptor agonists such as setmelanotide. [1] [2] [3] [4]

References

  1. Dimitri, Paul (6 April 2022). "Treatment of Acquired Hypothalamic Obesity: Now and the Future". Frontiers in Endocrinology. 13 846880. doi: 10.3389/fendo.2022.846880 . ISSN   1664-2392. PMC   9019363 . PMID   35464063.
  2. Bereket, A.; Kiess, W.; Lustig, R. H.; Muller, H. L.; Goldstone, A. P.; Weiss, R.; Yavuz, Y.; Hochberg, Z. (September 2012). "Hypothalamic obesity in children". Obesity Reviews. 13 (9): 780–798. doi:10.1111/j.1467-789X.2012.01004.x. PMID   22577758. S2CID   9550333.
  3. Abuzzahab, M. Jennifer; Roth, Christian L.; Shoemaker, Ashley H. (2019). "Hypothalamic Obesity: Prologue and Promise". Hormone Research in Paediatrics. 91 (2): 128–136. doi: 10.1159/000496564 . PMID   30884480. S2CID   83460590.
  4. Kim, Ja Hye; Choi, Jin-Ho (December 2013). "Pathophysiology and clinical characteristics of hypothalamic obesity in children and adolescents". Annals of Pediatric Endocrinology & Metabolism. 18 (4): 161–167. doi:10.6065/apem.2013.18.4.161. ISSN   2287-1012. PMC   4027083 . PMID   24904871.